UCI awarded $3.4M 'Cancer Moonshot' grant to study potential breakthrough in cancer
Share

IMAGE: Principal investigator, Michael Demetriou, MD, PhD, a professor of neurology, microbiology and molecular genetics and member of the NCI-designated Chao Comprehensive Cancer Center at UCI, along with his post-doctoral fellow,… view more 

Credit: University of California, Irvine

Irvine, Calif. – September 27, 2018 – UCI School of Medicine researchers have been awarded a $3.4 million grant by the National Cancer Institute (NCI) as part of the Beau Biden Cancer Moonshot initiative. The funding will support efforts to provide proof of principal data for an entirely new class of cancer killing immunotherapeutics with the potential to treat highly diverse types of cancer, from leukemia to breast cancer.

Principal investigator, Michael Demetriou, MD, PhD, a professor of neurology, microbiology and molecular genetics and member of the NCI-designated Chao Comprehensive Cancer Center at UCI, will lead the study entitled, “N-glycosylation and immunotherapy for cancer.”

“This grant epitomizes the kind of bench-to-bedside translational cancer research that is emerging from our NCI-designated cancer center,” said Richard Van Etten, MD, PhD, director of the UCI Chao Family Comprehensive Cancer Center. “Dr. Demetriou’s work, supported in part by a seed grant from the UCI Anti-Cancer Challenge event, has the potential to change our current paradigm

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD